Alzheimer's Disease Neuroimaging Initiative 4

Enrolling by invitation

Conditions studied: Mild Cognitive Impairment, Alzheimer Disease, Dementia

In brief

The Alzheimer's Disease Neuroimaging Initiative 4 (ADNI4) is a non-randomized, longitudinal, natural history study designed to validate biomarkers, improve clinical trial design, and advance understanding of Alzheimer's disease across the full disease spectrum. Building on the success of ADNI1, ADNI-GO, ADNI2, and ADNI3, ADNI4 integrates clinical, cognitive, imaging, genetic, and fluid biomarker data to characterize disease progression and predict cognitive decline. ADNI4 includes both in-clinic and remote cohorts and a small complementary sub-cohort, Together Exploring Aging Minds (TEAM-ADNI), which evaluates community-based recruitment and longitudinal data collection approaches.

Key facts

Study ID
NCT05617014
Run by
University of Southern California
People needed
1500
Starts
2023-06-09
Expected to finish
2027-07-31
Last updated by the study team
2026-07-06

Who can join

Age: 55 and older, up to 90. Sex: any. Healthy volunteers: accepted.

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.